- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Geistlich Pharma AG
Total 556 results
-
University of CologneSanofi; Novartis; Roche Pharma AGCompleted
-
Charite University, Berlin, GermanySanofi; Roche Pharma AGUnknown
-
Peking University Cancer Hospital & InstituteRoche Pharma AGUnknown
-
Fondazione Italiana Linfomi - ETSPierre Fabre Pharma AGNot yet recruiting
-
The Hospital for Sick ChildrenRoche Pharma AGNot yet recruiting
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
Washington University School of MedicineRoche Pharma AGRecruiting
-
Inna Chen, MDRoche Pharma AGRecruitingPancreatic Cancer | Lung Cancer, Nonsmall CellDenmark
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
GERCOR - Multidisciplinary Oncology Cooperative...Roche Pharma AGActive, not recruiting
-
Nykode Therapeutics ASARoche Pharma AG; Vaccibody ASCompletedCervical Cancer | Cervix CancerBelgium, Germany, Bulgaria, Czechia, Norway, Poland
-
Latin American Cooperative Oncology GroupRoche Pharma AGCompletedPenile Squamous Cell CarcinomaBrazil
-
Latin American Cooperative Oncology GroupRoche Pharma AGActive, not recruitingUterine Cervical NeoplasmsBrazil
-
Centre Hospitalier Universitaire de NīmesRoche Pharma AGCompletedMultiple Sclerosis | Clinically Isolated SyndromeFrance
-
Johannes Gutenberg University MainzRoche Pharma AG; ServierCompleted
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedComparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)ANCA-associated VasculitidesFrance
-
University of California, San FranciscoRoche Pharma AGCompletedHIV Infections | Cytomegalovirus InfectionsUnited States
-
Hospital Italiano de Buenos AiresRoche Pharma AGUnknownCOVID-19 | SARS-CoV 2 | Health Personnel
-
Fundación Academia Española de DermatologíaRoche Pharma AGCompletedMelanoma | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin Neoplasms | Histiocytoma, Malignant Fibrous | Dermatofibrosarcoma | Neoplasms, Adnexal and Skin AppendageSpain
-
Polish Myeloma ConsortiumRoche Pharma AG; Bioscience, S.A.UnknownWaldenstrom MacroglobulinemiaPoland
-
Hospital General Universitario Gregorio MarañonRoche Pharma AGUnknown
-
Groupe Francophone des MyelodysplasiesRoche Pharma AG; CelgeneCompletedMyelodysplastic SyndromesFrance, Monaco
-
Tehran University of Medical SciencesTillotts Pharma AGWithdrawnQuality of Life | Diarrhea- Predominant Irritable Bowel SyndromeIran, Islamic Republic of
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AGTerminatedColorectal Cancer | Liver MetastasesNetherlands
-
TME Pharma AGProfil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
Ontario Clinical Oncology Group (OCOG)Roche Pharma AGCompletedNon-small Cell Lung CancerCanada
-
Mashhad University of Medical SciencesRoche Pharma AGCompletedDMARD Resistant Rheumatoid ArthritisIran, Islamic Republic of
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
Royal Free Hampstead NHS TrustRoche Pharma AGCompleted
-
Pennine Acute Hospitals NHS TrustRoche Pharma AGUnknownHepatitis CUnited Kingdom
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Göteborg UniversityKing's College London; Charite University, Berlin, Germany; Geistlich Pharma AG; Queen Mary University of London and other collaboratorsNot yet recruitingPeriodontitis | Furcation DefectsSweden
-
Association Aquitaine de Recherche Clinique en...Roche Pharma AG; Chugai Pharma FranceCompletedArthritis, Rheumatoid | Tocilizumab | T-Lymphocytes, Helper-InducerFrance
-
University Hospital FreiburgRoche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbHCompletedDisorder Related to Renal TransplantationGermany
-
Gustave Roussy, Cancer Campus, Grand ParisRoche Pharma AGRecruiting
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
University Hospital, Basel, SwitzerlandNovartis Pharma AG, Basel, SwitzerlandCompletedMultiple Sclerosis (MS)Switzerland
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRoche Pharma AG; GFPCCompletedSmall Cell Lung CancerFrance
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
King's College LondonRoche Pharma AG; Medical Research CouncilCompletedKidney Transplantation | Graft Rejection | ImmunosuppressionUnited Kingdom
-
Centre Jean PerrinRoche Pharma AG; NanoString Technologies, Inc.Terminated
-
Molecular NeuroImagingRoche Pharma AG; Institute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD)United States
-
Göteborg UniversityThe Swedish Research Council; Roche Pharma AGCompleted
-
University College, LondonRoche Pharma AG; Cancer Research UKTerminatedLung Cancer | Metastatic CancerUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRoche Pharma AGCompletedSystemic Lupus Erythematosus | ANCA Associated VasculitisUnited Kingdom
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Medical University of ViennaRoche Pharma AG; Allcyte GmbHRecruitingRefractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell LymphomaAustria